TrialsgrambetaRCTs are beautiful

PEXIVAS

2020

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

In 704 patients with severe ANCA-associated vasculitis, plasma exchange did not reduce death or end-stage kidney disease compared with no plasma exchange.

Result

Efficacy: Composite of death or end-stage kidney diseaseHR 0.86 (95% CI 0.65-1.13)

Below 1 favours plasma exchange, above 1 favours no plasma exchange.

Also reported: Reduced-dose steroids non-inferior with fewer serious infections.

Original publication
Subtopic
ANCA vasculitis
Design
2×2 factorial RCT
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Walsh M, et al. N Engl J Med. 2020;382(7):622-631.doi 10.1056/NEJMoa1803537

Discussion & critique

Ended routine plasma exchange in ANCA vasculitis and made reduced-dose steroid schedules standard.

Discussed in podcasts